Anika Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE144Anika Therapeutics, Inc.ANIKAug 7

   William R Jellison, planned sale of ANIK shares

   William R Jellison, reporting

2. ROUTINE4Anika Therapeutics, Inc.ANIKAug 5

   Gary P Fischetti, insider filing for ANIK

   Gary P Fischetti, reporting

3. ROUTINESCHEDULE 13G/AAnika Therapeutics, Inc.ANIKJul 31

   Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC (amended)

   VANGUARD CAPITAL MANAGEMENT LLC, filed by

4. ROUTINES-8Anika Therapeutics, Inc.ANIKJul 29

   Employee stock plan registration

5. NOTABLE10-QAnika Therapeutics, Inc.ANIKJul 29

   Quarterly report

6. ROUTINE8-KAnika Therapeutics, Inc.ANIKJul 29

   Current report

7. ROUTINESCHEDULE 13G/AAnika Therapeutics, Inc.ANIKJul 17

   Ownership stake disclosure by BlackRock Portfolio Management LLC (amended)

   BlackRock Portfolio Management LLC, filed by

8. ROUTINE8-KAnika Therapeutics, Inc.ANIKJul 14

   Current report

9. ROUTINE4Anika Therapeutics, Inc.ANIKJun 23

   5 insider filings

   Sheryl L Conley, insider filing for ANIK

   Show all 5

   • 4Insider filing for ANIKJun 23
   • 4Insider filing for ANIKJun 23
   • 4Insider filing for ANIKJun 23
   • 4Insider filing for ANIKJun 23
   • 4Insider filing for ANIKJun 23

   Sheryl L Conley, reporting

10. ROUTINE8-KAnika Therapeutics, Inc.ANIKJun 23

    Current report

11. ROUTINEDEFA14AAnika Therapeutics, Inc.ANIKJun 8

    Additional proxy materials

12. ROUTINE4Anika Therapeutics, Inc.ANIKJun 5

    Stephen D. Griffin, insider filing for ANIK

    Stephen D. Griffin, reporting

13. ROUTINEDEFA14AAnika Therapeutics, Inc.ANIKJun 1

    Additional proxy materials

14. ROUTINE4Anika Therapeutics, Inc.ANIKMay 4

    John B Henneman III, insider filing for ANIK

    John B Henneman III, reporting

15. ROUTINE4Anika Therapeutics, Inc.ANIKApr 30

    Stephen D. Griffin, insider filing for ANIK

    Stephen D. Griffin, reporting

16. ROUTINESCHEDULE 13GAnika Therapeutics, Inc.ANIKApr 29

    Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

    VANGUARD CAPITAL MANAGEMENT LLC, filed by

17. ROUTINE8-KAnika Therapeutics, Inc.ANIKApr 29

    Current report

18. ROUTINEARSAnika Therapeutics, Inc.ANIKApr 28

    Annual report to shareholders

19. ROUTINEDEFA14AAnika Therapeutics, Inc.ANIKApr 28

    Additional proxy materials

20. ROUTINEDEF 14AAnika Therapeutics, Inc.ANIKApr 28

    Proxy statement

21. ROUTINESCHEDULE 13G/AAnika Therapeutics, Inc.ANIKMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

22. ROUTINE4Anika Therapeutics, Inc.ANIKMar 23

    Ian McLeod, insider filing for ANIK

    Ian McLeod, reporting

23. ROUTINE4Anika Therapeutics, Inc.ANIKMar 17

    4 insider filings

    David Colleran, insider filing for ANIK

    Show all 4

    • 4Insider filing for ANIKMar 17
    • 4Insider filing for ANIKMar 17
    • 4Insider filing for ANIKMar 17
    • 4Insider filing for ANIKMar 17

    David Colleran, reporting

24. ROUTINE4Anika Therapeutics, Inc.ANIKMar 11

    3 insider filings

    Ian McLeod, insider filing for ANIK

    Show all 3

    • 4Insider filing for ANIKMar 11
    • 4Insider filing for ANIKMar 11
    • 4Insider filing for ANIKMar 11

    Ian McLeod, reporting

25. ROUTINE8-KAnika Therapeutics, Inc.ANIKFeb 26

    Current report

26. ROUTINE4Anika Therapeutics, Inc.ANIKFeb 3

    Stephen D. Griffin, insider filing for ANIK

    Stephen D. Griffin, reporting

27. NOTABLESCHEDULE 13D/AAnika Therapeutics, Inc.ANIKJan 27

    Ownership stake disclosure by Caligan Partners LP (amended)

    Caligan Partners LP, filed by

28. ROUTINE8-KAnika Therapeutics, Inc.ANIKJan 8

    Current report

29. ROUTINESCHEDULE 13G/AAnika Therapeutics, Inc.ANIKJan 8

    Ownership stake disclosure by Trigran Investments, Inc. (amended)

    Trigran Investments, Inc., filed by

30. NOTABLESCHEDULE 13D/AAnika Therapeutics, Inc.ANIKNov 21, 2025

    Anika Therapeutics, Inc. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-21

    Caligan Partners LP, filed by

31. ROUTINESCHEDULE 13G/AAnika Therapeutics, Inc.ANIKNov 7, 2025

    Ownership stake disclosure by Trigran Investments, Inc. (amended)

    Trigran Investments, Inc., filed by

32. ROUTINES-8Anika Therapeutics, Inc.ANIKNov 5, 2025

    Employee stock plan registration

33. NOTABLE10-QAnika Therapeutics, Inc.ANIKNov 5, 2025

    Quarterly report

34. ROUTINE8-KAnika Therapeutics, Inc.ANIKNov 5, 2025

    Current report

Older filings on EDGAR